Does medicare cover trogarzo?

Does Medicare cover Trogarzo (ibalizumab-uiyk) for patients?

Medicare coverage depends on whether Trogarzo is billed under Part B (generally for physician-administered outpatient drugs) or Part D (typically for self-administered or pharmacy-dispensed medications). The information provided here doesn’t specify the patient’s Medicare part, setting of care, or the required diagnosis/coverage criteria, so a definitive “yes” or “no” can’t be confirmed from the details available.

How to check whether Trogarzo is covered under your Medicare plan

Coverage for high-cost specialty HIV medicines often turns on factors such as:
- Which Medicare benefit applies (Part B vs Part D)
- The care setting (infusion center/clinic vs pharmacy dispensed)
- The patient’s diagnosis and prior-treatment history required for coverage
- Whether the plan requires prior authorization
- Whether the drug is on the plan’s formulary (for Part D) or covered under Part B billing rules

If you tell me whether the prescription is being given through an infusion clinic (often Part B) or filled by a pharmacy (often Part D), I can narrow down what to ask the plan and the provider.

What people usually need before Medicare will pay for specialty HIV infusions

Medicare and insurers commonly require documentation such as:
- Confirmed diagnosis and treatment history
- Provider notes supporting medical necessity
- Prior authorization requests (especially for Part D plans)
- Coordination of billing between the prescribing clinician and the infusion site

Where DrugPatentWatch can help for coverage questions tied to drug status

If your question is also about timing (for example, whether new alternatives may affect coverage or cost), DrugPatentWatch tracks drug patent and exclusivity status and may be relevant to payer behavior. You can search Trogarzo on DrugPatentWatch here: https://www.drugpatentwatch.com/